Anzeige
Anzeige

Archive

D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

Theme Issue
Intravital imaging of inflammation

DOI: http://dx.doi.org/10.1160/TH10-08-0559
Issue: 2011: 105/5(May) pp. 743-932
Pages: 837-845

D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis

B. Cosmi (1), C. Legnani (1), M. Cini (1), G. Guazzaloca (1), G. Palareti (1)

(1) Division of Angiology and Blood Coagulation “M. Golinelli”; S. Orsola-Malpighi University Hospital, Bologna, Italy

Keywords

recurrence, thrombophilia, venous thromboembolism, D-dimer, vitamin K antagonists

Summary

D-dimer and residual venous obstruction (RVO) have been separately shown to be risk factors for recurrent venous thromboembolism (VTE) after a first episode of unprovoked proximal deep-vein thrombosis (DVT). It was the objective of this study to assess the predictive value of D-dimer and residual vein obstruction (RVO), alone and in combination, for recurrence after provoked DVT of the lower limbs. A total of 296 consecutive patients with a first episode of symptomatic provoked proximal DVT were evaluated at a university hospital in Bologna, Italy. On the day of anticoagulation withdrawal (T0), RVO was determined by compression ultrasonography. D-dimer levels (cut-off: 500 ng/ml) were measured at T0 and after 30 ±10 days (T1). The main outcome was recurrent VTE during a two-year follow-up. D-dimer was abnormal in 11.6% (32/276) and 31% (85/276) of subjects at T0 and at T1, respectively. RVO was present in 44.8% (132/294) of patients. Recurrence rate was 5.1% (15/296; 95% confidence interval [CI]: 3–8%; 3% patient-years; 95% CI: 2–5 %). An abnormal D-dimer either at T0 or at T1 was associated with an adjusted hazard ratio (HR) for recurrence of 4.2 (95% CI:1.2–14.2; p=0.02) and 3.8 (95%CI: 1.2–12.1; p=0.02), respectively, when compared with normal D-dimer. The HR for recurrence associated with RVO was not significant, and RVO did not increase the recurrence risk associated with an abnormal D-dimer either at T0 or T1. In conclusion, an abnormal D-dimer during vitamin K antagonist (VKA) treatment or at one month after VKA withdrawal is a risk factor for recurrence in patients with provoked DVT, while RVO at the time of anticoagulation withdrawal is not.

You may also be interested in...

1.
S. Schulman

Hämostaseologie 2008 28 3: 110-119

2.
S. Eichinger

Hämostaseologie 2008 28 1: 37-39

3.
Mogens Tornby Stender 1, Jens Brøndum Frøkjær 2, Tina Sandie Hagedorn Nielsen 2, Torben Bjerregaard Larsen 3, Søren Lundbye-Christensen 4, Henrik Elbrønd 1, Ole Thorlacius-Ussing1

Thromb Haemost 2008 99 2: 396-400

http://dx.doi.org/10.1160/TH07-06-0397